Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_assertion description "[l-2-Hydroxyglutaric aciduria (l-2-HGA) is characterized by progressive deterioration of central nervous system function including epilepsy and macrocephaly in 50% of cases, and elevated levels of l-2-hydroxyglutaric acid in urine, blood and cerebrospinal fluid (CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_assertion evidence source_evidence_literature NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_assertion SIO_000772 15385440 NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_assertion wasDerivedFrom befree-20140225 NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_assertion wasGeneratedBy ECO_0000203 NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP465350.RAu7X1P7e6CkQQ9VijUa4ktC1SD3nYMM1lafb5_AgVNlI130_provenance.